Download PDF
Thromb Haemost 2011; 106(04): 683-692
DOI: 10.1160/TH11-01-0030
Platelets and Blood Cells
Schattauer GmbH

Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients

Éva Csongrádi
1   1st Department of Medicine, Medical and Health Science Center, University of Debrecen, Hungary
2   Department of Physiology & Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Mississippi, USA
,
Bela Nagy Jr
3   Department of Clinical Biochemistry and Molecular Pathology, Medical and Health Science Center, University of Debrecen, Hungary
,
Tibor Fulop
4   Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi, USA
,
Zsuzsa Varga
1   1st Department of Medicine, Medical and Health Science Center, University of Debrecen, Hungary
,
Zsolt Karányi
1   1st Department of Medicine, Medical and Health Science Center, University of Debrecen, Hungary
,
Mária T. Magyar
5   Department of Neurology, Medical and Health Science Center, University of Debrecen, Hungary
,
László Oláh
5   Department of Neurology, Medical and Health Science Center, University of Debrecen, Hungary
,
Mária Papp
6   2nd Department of Medicine, Medical and Health Science Center, University of Debrecen, Hungary
,
Andrea Facskó
7   Department of Ophthalmology, Medical and Health Science Center, University of Debrecen, Hungary
,
János Kappelmayer
3   Department of Clinical Biochemistry and Molecular Pathology, Medical and Health Science Center, University of Debrecen, Hungary
,
György Paragh
1   1st Department of Medicine, Medical and Health Science Center, University of Debrecen, Hungary
,
Miklós Káplar
1   1st Department of Medicine, Medical and Health Science Center, University of Debrecen, Hungary
› Author Affiliations Financial support: This work was supported by a “Mecenatura” grant of Dr. Miklós Káplár (University of Debrecen, Hungary), by an OTKA grant (K75199) of Dr. János Kappelmayer, and by the TAMOP 4.2.1/B-091/1/KONV-2010-0007 project to Dr. János Kappelmayer.
Further Information

Publication History

Received: 18 January 2011

Accepted after minor revision: 18 June 2011

Publication Date:
29 November 2017 (online)

    Permissions and Reprints

Summary

The role of platelets in the development of atherosclerosis and obesity-related prothrombotic state is still under investigation. In this cross-sectional cohort study, we measured the levels of different platelet activation markers and evaluated their relationship with carotid intima-media thickness (IMT) along with other atherosclerotic risk factors in obese patients with or without atherosclerotic co-morbidities. We enrolled 154 obese patients, including 98 with either hypertension, type 2 diabetes mellitus or dyslipidaemia, 56 without these co-morbidities and 62 age- and sex-matched healthy controls. Platelet P-selectin expression and the number of platelet-derived microparticles (PMPs) were measured by flow cytometry; soluble P-selectin levels were analysed by ELISA and Thr715Pro P-selectin polymorphism was determined by PCR-RFLP. Carotid IMT was examined by ultrasonography. The levels of platelet activation parameters were significantly elevated in all obese subjects with increased carotid IMT compared to healthy controls. There was no effect of Thr715Pro genotype on soluble P-selectin levels in obese individuals contrary to normal subjects. Significant and positive association was revealed between carotid IMT and platelet P-selectin (p<0.0001), soluble P-selectin (p=0.039) and PMP (p=0.0001) levels. After adjusting for multiple variables, independent association was found between soluble P-selectin and fibrinogen (p=0.007), PMP levels and body mass index (p<0.0001) as well as platelet P-selectin and carotid IMT (p=0.012) plus plasminogen activator inhibitor-1 (p=0.009). In conclusion, P-selectin and PMP levels showed positive associations with abnormal carotid IMT and other risk factors in obesity suggesting a critical role of enhanced platelet reactivity in atherosclerotic wall alteration.

Keywords

Atherosclerosis - platelets - carotid intima-media thickness - P-selectin - microparticles - obesity - Thr715Pro polymorphism
 

  • References

  • 1 Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003; 24: 2166-2179.
    CrossrefPubMedGoogle Scholar
  • 2 Vidal C, Spaulding C, Picard F. et al. Flow cytometry detection of platelet pro-coagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation. Thromb Haemost 2001; 86: 784-790.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009; 102: 248-257.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Zeller JA, Tschoepe D, Kessler C. Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb Haemost 1999; 81: 373-377.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Shimizu M, Kohara S, Yamamoto M. et al. Significant relationship between platelet activation and intra-media thickness of the carotid artery in patients with ischemic cerebrovascular disease. Thromb Res 2006; 117: 647-652.
    CrossrefPubMedGoogle Scholar
  • 6 Ferroni P, Basili S, Falco A. et al. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2004; 2: 1282-1291.
    CrossrefPubMedGoogle Scholar
  • 7 Nagy Jr B, Csongrádi E, Bhattoa HP. et al. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thromb Haemost 2007; 98: 186-191.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Massberg S, Brand K, Grüner S. et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002; 196: 887-896.
    CrossrefPubMedGoogle Scholar
  • 9 Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 2661-2666.
    CrossrefPubMedGoogle Scholar
  • 10 Preston RA, Coffey JO, Materson BJ. et al. Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension. Atherosclerosis 2007; 192: 148-154.
    CrossrefPubMedGoogle Scholar
  • 11 Undas A, Wiek I, Stêpien E. et al. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 2008; 31: 1590-1595.
    CrossrefPubMedGoogle Scholar
  • 12 Ferroni P, Basili S, Davi G. Platelet activation, inflammatory mediators and hyper-cholesterolemia. Curr Vasc Pharmacol 2003; 1: 157-169.
    CrossrefPubMedGoogle Scholar
  • 13 Kappelmayer J, Nagy Jr B, Miszti-Blasius K. et al. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 2004; 42: 475-486.
    PubMedGoogle Scholar
  • 14 Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 2005; 3: 1590-1596.
    CrossrefPubMedGoogle Scholar
  • 15 George FD. Microparticles in vascular diseases. Thromb Res 2008; 122 (Suppl. 01) S55-59.
    CrossrefPubMedGoogle Scholar
  • 16 Davi G, Ferroni P. Microparticles in type 2 diabetes mellitus. J Thromb Haemost 2005; 3: 1166-1167.
    CrossrefPubMedGoogle Scholar
  • 17 De Pergola G, Pannacciulli N. Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest 2002; 25: 899-904.
    CrossrefPubMedGoogle Scholar
  • 18 Gallistl S, Sudi KM, Borkenstein M. et al. Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinolysis 2000; 11: 755-760.
    CrossrefPubMedGoogle Scholar
  • 19 Basili S, Pacini G, Guagnano MT. et al. Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 2006; 48: 2531-2538.
    CrossrefPubMedGoogle Scholar
  • 20 De Pergola G, Pannacciulli N, Coviello M. et al. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis 2008; 18: 227-232.
    CrossrefPubMedGoogle Scholar
  • 21 Goichot B, Grunebaum L, Desprez D. et al. Circulating procoagulant microparticles in obesity. Diabetes Metab 2006; 32: 82-85.
    CrossrefPubMedGoogle Scholar
  • 22 Murakami T, Horigome H, Tanaka K. et al. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res 2007; 119: 45-53.
    CrossrefPubMedGoogle Scholar
  • 23 Ueba T, Haze T, Sugiyama M. et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb Haemost 2008; 100: 280-285.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Samocha-Bonet D, Justo D, Rogowski O. et al. Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm 2008; 83: 4153-4158.
    PubMedGoogle Scholar
  • 25 Barbaux SC, Blankenberg S, Rupprecht HJ. et al. Associations between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Atheroscler Thromb Vasc Biol 2001; 21: 1668-1673.
    CrossrefPubMedGoogle Scholar
  • 26 Miller MA, Kerry SM, Dong Y. et al. Associations between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin in a multiethnic population in South London. Thromb Haemost 2004; 92: 1060-1065.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Reiner AP, Carlson CS, Thyagarajan B. et al. Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 2008; 28: 1549-1555.
    CrossrefPubMedGoogle Scholar
  • 28 Lorenz MW, Markus HS, Bots ML. et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115: 459-467.
    CrossrefPubMedGoogle Scholar
  • 29 Matthews DR, Hosker JP, Rudenski AS. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
    CrossrefPubMedGoogle Scholar
  • 30 Dobiásová M.. Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications. Clin Chem 2004; 50: 1113-1115.
    CrossrefPubMedGoogle Scholar
  • 31 Nagy Jr B, Szuk T, Debreceni IB. et al. Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone. Platelets 2010; 21: 147-151.
    CrossrefPubMedGoogle Scholar
  • 32 MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialists’ Collaborative Group. Lancet 1991; 337: 1235-1243.
    CrossrefPubMedGoogle Scholar
  • 33 Widder B, von Reutern GM, Neuerburg-Heusler D. Morphologic and Doppler sonographic criteria for determining the degree of stenosis of the internal carotid artery. Ultraschall Med 1986; 7: 70-75.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Howard G, Sharrett AR, Heiss G. et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993; 24: 1297-1304.
    CrossrefPubMedGoogle Scholar
  • 35 Lacoste L, Lam JY, Hung J. et al. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 1995; 92: 3172-3177.
    CrossrefPubMedGoogle Scholar
  • 36 Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
    CrossrefPubMedGoogle Scholar
  • 37 Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115-126.
    CrossrefPubMedGoogle Scholar
  • 38 Nagy Jr B, Jin J, Ashby B. et al. Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. J Thromb Haemost 2011; 9: 810-819.
    CrossrefPubMedGoogle Scholar
  • 39 Koyama H, Maeno T, Fukumoto S. et al. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003; 108: 524-529.
    CrossrefPubMedGoogle Scholar
  • 40 Fusegawa Y, Hashizume H, Okumura T. et al. Hypertensive patients with carotid artery plaque exhibit increased platelet aggregability. Thromb Res 2006; 117: 615-622.
    CrossrefPubMedGoogle Scholar
  • 41 Lukasik M, Rozalski M, Luzak B. et al. Platelet activation and reactivity in the convalescent phase of ischaemic stroke. Thromb Haemost 2010; 103: 644-650.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Kappelmayer J, Berecki D, Misz M. et al. Monocytes express tissue factor in young patients with cerebral ischemia. Cerebrovasc Dis 1998; 8: 235-239.
    CrossrefPubMedGoogle Scholar
  • 43 Schneider DJ, Hardison RM, Lopes N. et al. Pro-Thrombosis Ancillary Study Group. Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy. Diabetes Care 2009; 32: 944-949.
    CrossrefPubMedGoogle Scholar
  • 44 Pannacciulli N, Cantatore FP, Minenna A. et al. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 2001; 25: 1416-1420.
    CrossrefPubMedGoogle Scholar
  • 45 Rosito GA, D'Agostino RB, Massaro J. et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 2004; 91: 683-689.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 46 Pannacciulli N, De Mitrio V, Marino R. et al. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects. Obes Res 2002; 10: 717-725.
    CrossrefPubMedGoogle Scholar
  • 47 Juhan-Vague I, Alessi MC, Mavri A. et al. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 2003; 1: 1575-1579.
    CrossrefPubMedGoogle Scholar
  • 48 Bucciarelli P, Sramek A, Reiber JH, Rosendaal FR. Arterial intima-media thickness and its relationship with cardiovascular disease and atherosclerosis: a possible contribution of medium-sized arteries. Thromb Haemost 2002; 88: 961-966.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Du XJ, Shan L, Gao XM, Kiriazis H, Liu Y, Lobo A, Head GA, Dart AM. Role of intramural platelet thrombus in the pathogenesis of wall rupture and intraventricular thrombosis following acute myocardial infarction. Thromb Haemost 2011; 105: 356-364.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Fateh-Moghadam S, Li Z, Ersel S. et al. Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler Thromb Vasc Biol 2005; 25: 1299-1303.
    CrossrefPubMedGoogle Scholar
  • 51 Balla J, Magyar MT, Bereczki D. et al. Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease. Dis Markers 2006; 22: 133-140.
    CrossrefPubMedGoogle Scholar
  • 52 Volcik KA, Ballantyne CM, Coresh J. et al. P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: The Atherosclerosis Risk In Communities Study. Atherosclerosis 2006; 186: 74-79.
    CrossrefPubMedGoogle Scholar